RO88924A - Procedeu de obtinere a unui preparat de cefaclor cu actiune prelungita - Google Patents

Procedeu de obtinere a unui preparat de cefaclor cu actiune prelungita

Info

Publication number
RO88924A
RO88924A RO84114861A RO11486184A RO88924A RO 88924 A RO88924 A RO 88924A RO 84114861 A RO84114861 A RO 84114861A RO 11486184 A RO11486184 A RO 11486184A RO 88924 A RO88924 A RO 88924A
Authority
RO
Romania
Prior art keywords
cephachlore
prepare
obtaining
prolonged action
cefaclor
Prior art date
Application number
RO84114861A
Other languages
English (en)
French (fr)
Inventor
Sakamoto Teruo
Kawai Sadao
Noda Kinzaburo
Takeda Toyohico
Kato Hiroshi
Original Assignee
Shionogi And Co.Ltd,Jp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi And Co.Ltd,Jp filed Critical Shionogi And Co.Ltd,Jp
Publication of RO88924A publication Critical patent/RO88924A/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RO84114861A 1983-06-15 1984-06-13 Procedeu de obtinere a unui preparat de cefaclor cu actiune prelungita RO88924A (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58108289A JPS601128A (ja) 1983-06-15 1983-06-15 作用持続型セフアクロル製剤

Publications (1)

Publication Number Publication Date
RO88924A true RO88924A (ro) 1986-04-30

Family

ID=14480890

Family Applications (1)

Application Number Title Priority Date Filing Date
RO84114861A RO88924A (ro) 1983-06-15 1984-06-13 Procedeu de obtinere a unui preparat de cefaclor cu actiune prelungita

Country Status (23)

Country Link
US (1) US4713247A (ro)
EP (1) EP0129382B1 (ro)
JP (1) JPS601128A (ro)
KR (1) KR910004573B1 (ro)
AT (1) ATE56869T1 (ro)
AU (1) AU568654B2 (ro)
BG (1) BG60261B2 (ro)
CA (1) CA1213218A (ro)
DD (1) DD216163A5 (ro)
DE (1) DE3483282D1 (ro)
DK (2) DK291884A (ro)
ES (1) ES8602407A1 (ro)
FI (1) FI84556C (ro)
GB (1) GB2141342B (ro)
GR (1) GR81598B (ro)
HU (1) HU193434B (ro)
IE (1) IE58278B1 (ro)
IL (1) IL72083A (ro)
NZ (1) NZ208345A (ro)
PH (1) PH19902A (ro)
PT (1) PT78699B (ro)
RO (1) RO88924A (ro)
ZA (1) ZA844357B (ro)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
JPH0714863B2 (ja) * 1986-06-02 1995-02-22 忠生 白石 時差溶解性の入浴剤
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
BE1002079A4 (fr) * 1988-07-01 1990-06-19 S M B Lab Composition pharmaceutique d'erythromycine a liberation prolongee, sa preparation et son utilisation.
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
GB9318641D0 (en) * 1993-09-08 1993-10-27 Edko Trading Representation Compositions
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
AU5107496A (en) * 1996-03-13 1997-10-01 Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh Medicament preparation for angiotensin converting enzyme (ace)-inhibitors
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
ZA98728B (en) * 1998-01-29 1998-10-28 Ranbaxy Lab Ltd Modified release matrix formulations of cefactor and cephalexin
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
WO2000059481A1 (en) * 1999-04-06 2000-10-12 Pharmaquest Ltd. PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
WO2000069417A1 (en) * 1999-05-14 2000-11-23 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
US6596307B1 (en) 1999-06-15 2003-07-22 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
AU3986901A (en) * 2000-02-24 2001-09-03 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
JP2003523372A (ja) * 2000-02-24 2003-08-05 アドバンシス ファーマシューティカル コーポレイション 抗生物質及び抗真菌剤組成物
WO2001062229A1 (en) * 2000-02-24 2001-08-30 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
WO2002056867A2 (en) * 2001-01-18 2002-07-25 Natco Pharma Limited Extended release pharmaceutical compositions containing beta-lactam antibiotics
WO2003075852A2 (en) * 2002-03-07 2003-09-18 Advancis Pharmaceuticals Corporation Antibiotic composition
AU2003219184A1 (en) * 2002-05-09 2003-11-11 Diffucap-Chemobras Quimica E Farmaceutica, Ltda. Novel method of preparing programmed-release compositions containing (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline and the product thus obtained
WO2005009365A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648407A4 (en) * 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2007502294A (ja) * 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
BR0318535A (pt) * 2003-09-30 2006-09-12 Lupin Ltd composição farmacêutica para o envio controlado de droga, processo para a preparação de uma composição farmacêutica e composição de liberação controlada
CN101184477A (zh) * 2005-04-12 2008-05-21 依兰药物国际有限公司 治疗细菌感染的含头孢菌素控释组合物
JP2008545841A (ja) 2005-06-02 2008-12-18 ノボザイムス アクティーゼルスカブ 不活性粒子及び活性粒子のブレンド
US20060287212A1 (en) * 2005-06-02 2006-12-21 Novozymes A/S Blends of inactive particles and active particles
DK2391355T3 (en) 2009-05-19 2017-02-27 Celgene Corp FORMULATIONS OF 4-AMINO-2- (2,6-DIOXOPIPERIDIN-3-YL) ISOINDOLIN-1,3-DION
CN110384701A (zh) * 2011-12-19 2019-10-29 萨利克斯药品有限公司 使用甲基纳曲酮口服组合物治疗和预防阿片类诱发型便秘的方法
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN104688701A (zh) * 2015-03-20 2015-06-10 江苏亚邦强生药业有限公司 一种头孢克洛片剂及其制备方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN110408670A (zh) * 2019-08-19 2019-11-05 苏州盛达药业有限公司 一种酶催化合成头孢克洛的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
JPS52139713A (en) * 1976-05-13 1977-11-21 Shionogi & Co Ltd Sustained release cefalexin preparations
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GR74995B (ro) * 1980-08-27 1984-07-12 Ciba Geigy Ag
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤

Also Published As

Publication number Publication date
NZ208345A (en) 1986-12-05
EP0129382A3 (en) 1986-07-09
HUT34692A (en) 1985-04-28
DK170922B1 (da) 1996-03-18
PT78699A (pt) 1985-01-01
ZA844357B (en) 1985-06-26
GB2141342A (en) 1984-12-19
BG60261B1 (bg) 1994-03-31
DK291884A (da) 1984-12-16
GR81598B (ro) 1984-12-11
IE841444L (en) 1984-12-15
PH19902A (en) 1986-08-13
FI842406A0 (fi) 1984-06-13
FI84556C (fi) 1991-12-27
KR910004573B1 (ko) 1991-07-06
ES533901A0 (es) 1985-12-01
GB2141342B (en) 1986-11-12
IE58278B1 (en) 1993-08-25
ATE56869T1 (de) 1990-10-15
AU568654B2 (en) 1988-01-07
FI84556B (fi) 1991-09-13
DE3483282D1 (de) 1990-10-31
GB8414633D0 (en) 1984-07-11
IL72083A0 (en) 1984-10-31
CA1213218A (en) 1986-10-28
FI842406A (fi) 1984-12-16
US4713247A (en) 1987-12-15
JPS601128A (ja) 1985-01-07
JPS6232166B2 (ro) 1987-07-13
KR850000242A (ko) 1985-02-26
AU2941884A (en) 1984-12-20
IL72083A (en) 1987-10-30
BG60261B2 (en) 1994-03-31
DK291884D0 (da) 1984-06-14
DD216163A5 (de) 1984-12-05
HU193434B (en) 1987-10-28
EP0129382A2 (en) 1984-12-27
PT78699B (en) 1986-07-15
ES8602407A1 (es) 1985-12-01
EP0129382B1 (en) 1990-09-26

Similar Documents

Publication Publication Date Title
RO88924A (ro) Procedeu de obtinere a unui preparat de cefaclor cu actiune prelungita
MA19639A1 (fr) Procede de preparation de derives de l'acide cis, endo-2-azabicyclo- (3,3,0) -octane-3- carboxylique et d'agents contenant ces derives
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
HUT66238A (en) Bicyclic carboxylic acid derivatives, pharmaceutical compositions contg. them as active agent and process to prepare them
BE887752A (fr) Derives de l'acide 7-oxo-1-azabicyclo (3,2,0) hept-2-ene-2-carboxylique, leur procede de preparation et leur application notamment comme antibiotiques
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
BE896478A (fr) DERIVES N-CARBAMOYLE D'ISOTHIAZOLO-(5,4b) PYRIDINE ONE-3 ET LEUR PROCEDE DE PREPARATION
BR9205255A (pt) Aril aquil esteres de acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antraceno carboxilico com atividade terapeutica
FR2606789B1 (fr) Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
BE892292A (fr) Substance biologiquement active, procede de preparation de cette substance et composition immunoactive
IT8468196A1 (it) Dispositivo osmotico e procedimento per l'erogazione di un agente benefico, particolarmente di un farmaco ad un ambiente d'uso.
BE864122A (fr) Composition de pentapeptide, son procede d'obtention et composition therapeutique en comporatant
ES8307811A1 (es) "procedimiento para la preparacion de nuevas imidazo 1,2-a pirimidinas".
FR2547814B1 (fr) Derives de l'acide bicyclo (3.2.1.) octane carboxylique, leur procede de preparation et leur application therapeutique
HUT35926A (en) Compositions for treating plant diseases and process for producing substituted benzopenta-thiepine derivatives utilizable as active agents
BE891468A (fr) Derives d'imidazole, leur procede de preparation et leur application therapeutique
FR2487201B2 (fr) Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications
ES8504824A1 (es) Un procedimiento para la preparacion de un compuesto de sultamicilina
FR2616441B1 (fr) Procede de preparation d'additifs surbases et compositions renfermant lesdits additifs
FR2518571B1 (fr) Agent de decomposition de la remanence vegetale, procede de preparation d'une proteine vegetale purifiee utilisant cet agent et proteine vegetale purifiee ainsi obtenue
FR2589479B1 (fr) Nouvel enzyme, son procede d'obtention et son application a la preparation de n-(l-aspartyl-1)l-phenylalaninate de methyle
GB8800357D0 (en) Teat treating compositions production & use thereof
FR2624342B1 (fr) Procede d'obtention de plantes transgeniques, vecteur d'integration utilise et plantes obtenues
FR2579206B1 (fr) Nouvelles 5-h pyrido (3', 4' : 4,5) (pyrrolo 3,2-c) pyridones, leur procede de preparation et leur application en tant qu'intermediaires de synthese